Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence (AI). 
The NHS exists to serve patients. But more could be done to make their experience a key focus when it comes to technology adoption, senior NHS delegates told a recent roundtable. SPARK TSL reports.
Sustained challenges faced by clinical teams on the frontline of an NHS under pressure are well documented in daily headlines.
Bayer and Hologic, Inc., today announced an international partnership to deliver contrast-enhanced-mammography (CEM) solutions to improve the detection of breast cancer in multiple countries across Canada, the European and Asia Pacific regions.
CEM is an innovative highly sensitive and low-cost breast imaging modality which combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.
Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit business and a new vision for the NHS, based on patient engagement and application services. 
The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens
and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due to the ongoing changes within the Health Industry. To accommodate these changes, sundhed.dk uses the Chatbot
from SupWiz to solve urgent needs for support and provides a nice citizen experience. Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.